Ivy Biosciences — AI-Powered Drug Discovery Platform

Ivy Biosciences is an open-source AI drug discovery platform that orchestrates 45+ computational biology models — from protein folding and molecular docking to ADMET prediction and retrosynthesis — into complete pre-clinical workflows. The platform, called .bloom*, connects open-source tools and biomedical databases so researchers can move from target identification to synthesis planning in a single environment.

Platform Capabilities

Pricing

Free Seed tier with 500 credits per month. Paid plans (Grow, Flourish) for teams needing higher throughput. Student plan with free enhanced access for verified .edu emails. Enterprise plans with dedicated support and custom integrations.

Use Cases

Documentation

Comprehensive guides covering a comprehensive set of tools organized by the drug discovery pipeline: target identification, structure analysis, hit discovery, lead optimization, ADMET and safety, and synthesis planning. Includes quickstarts, API references, and CLI documentation.

Open source under FSL-1.1-Apache-2.0 (converts to Apache 2.0 after 2 years). Self-hosting documentation available at ivybiosciences.com/docs.

Skip to main content

    Loading…